The interaction of drug- and psychotherapy in the long-term treatment of depression

Journal of Affective Disorders

Volumn 62, Issue 1-2, 2001, Pages 131-137

  Kupfer, David J ^a   Frank, Ellen ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Combination treatment; Long term treatment; Recurrence

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; IMIPRAMINE; NORTRIPTYLINE; PAROXETINE; SERTRALINE;

ARTICLE; DEPRESSION; DISEASE COURSE; HUMAN; LONG TERM CARE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY; RECURRENCE RISK; SHORT COURSE THERAPY;

EID: 0035147385     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(00)00357-8     Document Type: Review

References (38)

1. Factors associated with incomplete recovery in primary depressive illness
2. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: A meta-analysis
3. Natural history and epidemiology of depression: Results of community studies
4. Course of unipolar, bipolar affective and schizoaffective disorders. Results of a prospective study from 1959 to 1985
5. Recovery from depression: Risk or reality?
6. Sertraline in the prevention of depression
7. The Zurich Study. XVI. Early antecedents of depression. A longitudinal prospective study on incidence in young adults
8. Relapse in patients on long-term fluoxetine: Response to increased fluoxetine dose
9. A double-blind study of long-term treatment with sertraline or fluvoxamine for the prevention of highly recurrent unipolar depression
10. Three-year outcomes for maintenance therapies in recurrent depression
11. Conceptualization and rationale for consensus definitions of terms of major depressive disorder: Remission, recovery, relapse, and recurrence
12. Relationship of pharmacologic compliance to long-term prophylaxis in recurrent depression
13. Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression
14. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders
15. Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression
16. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness
17. Maintenance phase efficacy of sertraline for chronic depression: A randomized controlled trial
18. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey
19. The current age of youthful melancholia: Evidence for increase in depression among adolescents and young adults
20. Long-term treatment of depression
21. Five-year outcome for maintenance therapies in recurrent depression
22. Recurrence after recovery in unipolar MDD: An observational follow-up study of clinical predictors and somatic treatment as a mediating factor
23. The long-term outcome of Maudsley depressives
24. Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression
25. The prophylactic efficacy of fluoxetine in unipolar depression
26. A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression
27. Selective serotonin reuptake inhibitors: Metaanalysis of discontinuation
28. Relapse, recurrence and chronicity in depression
29. Continuation drug therapy for major depressive episodes: How long should it be maintained?
30. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders: A report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination
31. Optimal length of continuation therapy in depression: A prospective assessment during long-term fluoxetine treatment
32. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: A randomized controlled trial in patients older than 59 years
33. Strategies and tactics in the treatment of depression
34. Polysomnographic findings in recently drug-free and clinically remitted depressed patients
35. Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo
36. Current status of EEG sleep in the assessment and treatment of depression
37. Sleep EEG and DST findings in anergic bipolar depression